Company: NDRA
Filing Date: 2025-10-28
Form Type: DEF 14A
Source: 0001654954-25-012254
Chunk: 13

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-28
Form: DEF 14A
Chunk 13
---
 of Mr. Lipman reported in this table reflects this limitation. The address of Mr. Lipman is 570 Lexington Avenue, 40th Floor, New York, New York 10022.                                                                                                                                                                                                                                  |
| (10) | Mr. Rivero’s address is 14521 Jockey Circle, N. Davie, FL 33330.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

<div align='center'>PROPOSAL 1 ‒ELECTION OF DIRECTORS</div>

The Company’s Board of Directors currently consists of four members. Upon the recommendation of the Corporate Governance and Nominating Committee of our Board of Directors, the Board of Directors has nominated the four current directors for election at the 2025 Annual Meeting to hold office until the next annual meeting of stockholders (each to serve until his successor is duly elected and qualified or until his earlier death, resignation, or removal).

Shares represented by all proxies received by the Board of Directors and not marked so as to withhold authority to vote for any individual nominee will be voted FOR the election of the nominees named below. The Board of Directors knows of no reason why any nominee would be unable or unwilling to serve, but if such should be the case, proxies may be voted for the election of some other person nominated by the Board of Directors.

<div align='center'>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS

A VOTE FOR THE NOMINEES LISTED BELOW</div>

The following table sets forth the nominees to be elected at the 2025 Annual Meeting, their age, and the positions currently held by each director with ENDRA.

| Name                   |     | Age |     | Position                             |
| Alexander Tokman       |     |  63 |     | Chief Executive Officer and Chairman |
| Louis J. Basenese      |     |  47 |     | Director                             |
| Anthony DiGiandomenico |     |  58 |     | Director                             |
| Michael Harsh          |     |  71 |     | Director                             |

<div align='center'>INFORMATION CONCERNING DIRECTORS AND NOMINEES FOR DIRECTOR</div>

Biographical information with respect to our executive officers and directors is provided below. There are no family relationships between any of our executive officers or directors.

Alexander Tokman joined ENDRA’s Board of Directors in 2008 and was appointed as the Company’s Chief Executive Officer and Chairman of the Board of Directors on August 13,